Bronchiolitis News and Research

RSS

FDA clears test for 12 specific respiratory viruses

The U.S. Food and Drug Administration has cleared for marketing a test that simultaneously detects and identifies 12 specific respiratory viruses.

4 Jan 2008

Study of the post-transplant effects of alcohol use among lung donors

A recent study using an animal model of lung transplants shows that chronic alcohol consumption by the donor promotes scarring and airway injury after transplantation.

2 Dec 2007

Alcohol may promote scarring and airway injury after transplantation

A recent study using an animal model of lung transplants shows that chronic alcohol consumption by the donor promotes scarring and airway injury after transplantation.

27 Nov 2007

New human rhinovirus associated with pediatric respiratory tract infection in Germany

Using a rapid, sensitive, and inexpensive diagnostic tool called MassTag PCR, scientists at Columbia University Mailman School of Public Health's Center for Infection and Immunity implicated a new human rhinovirus as the cause of severe pediatric respiratory tract infections in Europe.

21 Nov 2007

Scientists find predisposition to bronchiolitis in some babies

Scientists have found that a large proportion of infants who suffer from bronchiolitis have an inherent pre-disposition to the disease.

22 Oct 2007

Culprit in 'popcorn lung' identified

Scientists have pinpointed an ingredient in microwaved popcorn that could be the culprit in cases of "popcorn lung", a disease which affects people who work in the popcorn making industry.

4 Sep 2007

Diacetyl is a respiratory hazard

Researchers in the Netherlands have identified a chemical agent that may be a, if not the, culprit in bronchiolitis obliterans syndrome (BOS), or “popcorn worker's lung,” a severe occupational lung disease first noted in 2001 among workers at an American plant that makes microwaveable popcorn.

3 Sep 2007

Treating bronchiolitis with steroids doesn't work

For infants with a common and potentially serious viral lower respiratory infection called bronchiolitis, a widely used steroid treatment is not effective.

27 Jul 2007

Dexamethasone steroid treatment shows no benefit for kids with bronchiolitis

DMC Children's Hospital of Michigan has found that a common steroid treatment often prescribed for kids with bronchiolitis has no impact on improving their symptoms or in reducing hospitalization.

26 Jul 2007

Steroid medications don't work in treating lower respiratory infections in children

The use of steroid medication to treat bronchiolitis, a common viral lower respiratory infection in infants , does not prevent hospitalization or improve their respiratory symptoms, according to a study published in the July 26 issue of The New England Journal of Medicine.

26 Jul 2007

Biota and MedImmune announce clinical trial for respiratory syncytial virus antiviral drug

Biota Holdings Limited and MedImmune Inc. today announced the start of a Phase Ia clinical trial for their respiratory syncytial virus (RSV) antiviral drug, BTA9881, with the goal of providing a treatment for RSV-infected infants and adults.

17 Jul 2007

Include children in research to make breakthroughs in child medicine

Scientists will only make real breakthroughs in children's medicine if they include children in research programmes as well as adults, according to a leading paediatric expert.

9 Jul 2007

Pepsin associated with acute rejection of a lung transplant

Researchers in the United Kingdom have demonstrated that high levels of pepsin, a digestive enzyme that is a marker for gastric aspiration, are associated with acute rejection of a lung transplant.

19 Jun 2007

Albuterol may help kids with bronchiolitis

Bronchiolitis, a wheezing much like asthma in adults, is responsible for many hospital admissions of infants.

17 May 2007

New vaccine breakthrough for respiratory syncytial virus

Respiratory syncytial virus (RSV) infection is a widespread infant illness that has been linked to asthma and can be deadly but may be curable by the development of this new vaccine technology by the Sir Albert Sakzewski Virus Research Centre and The University of Queensland's Faculty of Biological and Chemical Sciences.

9 May 2007